Monday, November 30, 2009 2:23:54 PM
Remmeber, too, that we have no revenues (royalties) yet so much of the price volatility is predicated on lots of guesses about what our potential income stream will be from the prostate test. And, remember, too, that we do yet know if and when the test will roll out and how quickly it will be adopted and how widely accepted it may become and what it will be priced at---which will determine our royalty flow. Further, we have other tests in "development" and thier timelines cannot be predicted with any certainty at this time either.
And then today's announcement mentioned that Tom Gallagher will pursue non-medical applications for our technology and no one knows how soon, how many, how much. I do believe that this too will happen but I have no idea when...other than saying that I believe it will happen and I'll be happy with this and all the other results.
In the end, truth will out and this stock, like all others, will find its true price level.
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:10:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 09:13:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 07:53:39 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM